This website uses cookies and other technologies to help us provide you with better content and customized services. If you want to continue to enjoy this website’s content, please agree to our use of cookies. For more information on cookies and their use, please see our latest Privacy Policy.

Accept

cwlogo

切換側邊選單 切換搜尋選單

Vol. 726 / Content

Vaccine blues: When is it your turn?

Vol. 726

purchase subscribe

International

CCP at 100: All powerful but alone

As the Chinese Communist Party celebrates its 100th anniversary, China has never been more confident or more isolated on the world stage. How will the unprecedented pressure it is facing from the West affect U.S.-China relations, and is conflict inevitable?

International

Taiwan businesses: Exiting China not an option amid struggle for survival

The COVID-19 pandemic has brought a new dawn for Chinese manufacturing, with Chinese firms squeezing out Taiwanese competitors from the Apple supply chain. Caught in the middle of the China-U.S. trade war, Taiwanese businesses need to transform to stay in the game, whether they stay in China or leave.

Politics & Society

How far is Taiwan from herd immunity?

The US has sent 2.5 million doses of the Moderna COVID-19 vaccine, but Taiwan has only taken delivery on one million purchased doses. When will Taiwan’s populace have enough vaccines, and how far are we from herd immunity?

Politics & Society

On the trail of the COVID-19 vaccine Holy Grail

Soon after COVID-19 erupted, a Texas university lab isolated proteins that helped U.S. companies develop vaccines in record time. It then came up with a potentially game-changing 2nd-generation protein, described in a study in which the lead author was Taiwanese. Here’s how they did it, and what it may mean.